BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11127749)

  • 21. Experience in managing a large-scale rescreening of Papanicolaou smears and the pros and cons of measuring proficiency with visual and written examinations.
    Rube IF
    Acta Cytol; 1989; 33(4):479-83. PubMed ID: 2546349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell preparation methods and criteria for sample adequacy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    McGoogan E; Colgan TJ; Ramzy I; Cochand-Priollet B; Davey DD; Grohs HK; Gurley AM; Husain OA; Hutchinson ML; Knesel EA; Linder J; Mango LJ; Mitchell H; Peebles A; Reith A; Robinowitz M; Sauer T; Shida S; Solomon D; Topalidis T; Wilbur DC; Yamauchi K
    Acta Cytol; 1998; 42(1):25-32. PubMed ID: 9479321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality assurance in cytology: New York State Proficiency Testing Program.
    Collins DN; Newton LE
    QRB Qual Rev Bull; 1989 Jul; 15(7):215-22. PubMed ID: 2505208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summary of the 2006 College of American Pathologists Gynecologic Cytology Proficiency Testing Program.
    Bentz JS; Hughes JH; Fatheree LA; Schwartz MR; Souers RJ; Wilbur DC;
    Arch Pathol Lab Med; 2008 May; 132(5):788-94. PubMed ID: 18466027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
    Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
    Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current manpower pool in cytotechnology.
    Clark AH
    Acta Cytol; 1989; 33(4):455-9. PubMed ID: 2750435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations that could improve performance of colposcopy and cytology.
    Dina R
    Cytopathology; 2008 Dec; 19(6):338-40. PubMed ID: 19040544
    [No Abstract]   [Full Text] [Related]  

  • 28. Quality assurance and risk reduction guidelines.
    Mody DR; Davey DD; Branca M; Raab SS; Schenck UG; Stanley MW; Wright RG; Arbyn M; Beccati D; Bishop JW; Collaço LM; Cramer SF; Fitzgerald P; Heinrich J; Jhala NC; Montanari G; Kapila K; Naryshkin S; Suprun HZ
    Acta Cytol; 2000; 44(4):496-507. PubMed ID: 10934940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of herpes simplex challenges in proficiency testing: observations from the College of American Pathologists proficiency testing program.
    Moriarty AT; Darragh TM; Souers R; Fatheree LA; Wilbur DC
    Arch Pathol Lab Med; 2009 Sep; 133(9):1379-82. PubMed ID: 19722743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BAC recommended code of practice for cytology laboratories participating in the UK cervical screening programmes 2015 - an introduction.
    Smart LM
    Cytopathology; 2016 Feb; 27(1):5-7. PubMed ID: 26818037
    [No Abstract]   [Full Text] [Related]  

  • 31. Proficiency testing in cytology in New York. Analysis of a 14-year state program.
    Collins DN; Patacsil DP
    Acta Cytol; 1986; 30(6):633-42. PubMed ID: 3466500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scientific issues related to the cytology proficiency testing regulations.
    Cytopathology Education and Technology Consortium
    Acta Cytol; 2006; 50(2):191-7. PubMed ID: 16610688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of staff performance and interpretation of the screening program for prevention of thalassemia.
    Prommetta S; Sanchaisuriya K; Fucharoen G; Yamsri S; Chaiboonroeng A; Fucharoen S
    Biochem Med (Zagreb); 2017 Jun; 27(2):387-397. PubMed ID: 28694728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive internal quality control system for a large cytology laboratory.
    Anderson GH; Flynn KJ; Hickey LA; Le Riche JC; Matisic JP; Suen KC
    Acta Cytol; 1987; 31(6):895-9. PubMed ID: 3425151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Society for Cytotechnology quality assurance survey data. Summary report.
    Ashton PR
    Acta Cytol; 1989; 33(4):451-4. PubMed ID: 2750434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. With an eye toward patient care.
    Selvaggi SM
    Diagn Cytopathol; 2004 Apr; 30(4):217-9. PubMed ID: 15048953
    [No Abstract]   [Full Text] [Related]  

  • 39. Cervical cytology quality assurance in Washington State.
    Taylor V; Frost F
    Acta Cytol; 1992; 36(2):246-50. PubMed ID: 1543009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Yorkshire slide exchange external quality assessment (EQA) scheme.
    Boon AP; Williamson P; Brown JM; Thomas GD
    Cytopathology; 1996 Apr; 7(2):90-8. PubMed ID: 9074658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.